These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29708877)

  • 21. Does proficiency testing improve the quality of hantavirus serodiagnostics? Experiences with INSTAND EQA schemes.
    Hofmann J; Grunert HP; Donoso-Mantke O; Zeichhardt H; Kruger DH
    Int J Med Microbiol; 2015 Oct; 305(7):607-11. PubMed ID: 26342877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods Comparison and Bias Estimation of Three Distinct Biochemistry Analytical Systems in One Clinical Laboratory Using Patient Samples.
    Fu H; Yan S; Wang Y; Gu D; Li X; Yang G; Liu Y
    Clin Lab; 2016; 62(1-2):187-94. PubMed ID: 27012049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The analytical performance of laboratory plasma glucose and HbA
    Mosca A; Quercioli M; Paleari R
    Acta Diabetol; 2020 Feb; 57(2):215-219. PubMed ID: 31435784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Internal Quality Control and External Quality Assessment on POCT].
    Kuwa K
    Rinsho Byori; 2015 Feb; 63(2):224-31. PubMed ID: 26529974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Precision and Bias Specifications Required to Achieve the 2018 FDA Guidance Criteria for Glucose Meter Performance Using Simulation Models.
    Lyon AW; Lyon ME
    J Diabetes Sci Technol; 2020 May; 14(3):513-518. PubMed ID: 31752535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. I. Method setup.
    Stöckl D; Reinauer H
    Clin Chem; 1993 Jun; 39(6):993-1000. PubMed ID: 8504568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the impact of standardization process on the quality of serum creatinine determination in Italian laboratories.
    Carobene A; Ceriotti F; Infusino I; Frusciante E; Panteghini M
    Clin Chim Acta; 2014 Jan; 427():100-6. PubMed ID: 24144863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance characteristics of automated clinical chemistry analyzers using commercial assay reagents contributing to quality assurance and clinical decision in a hospital laboratory.
    Tzortzopoulos A; Raftopoulos V; Talias MA
    Scand J Clin Lab Invest; 2020 Feb; 80(1):46-54. PubMed ID: 31766906
    [No Abstract]   [Full Text] [Related]  

  • 29. Accuracy and precision of point-of-care testing for glucose and prothrombin time at the critical care units.
    Yuoh C; Tarek Elghetany M; Petersen JR; Mohammad A; Okorodudu AO
    Clin Chim Acta; 2001 May; 307(1-2):119-23. PubMed ID: 11369346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance evaluation of blood glucose monitoring devices.
    Chen ET; Nichols JH; Duh SH; Hortin G
    Diabetes Technol Ther; 2003; 5(5):749-68. PubMed ID: 14633341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a new generation POCT glucose device with emphasis on aspects important for glycemic control in the hospital care.
    Kos S; van Meerkerk A; van der Linden J; Stiphout T; Wulkan R
    Clin Chem Lab Med; 2012; 50(9):1573-80. PubMed ID: 23092803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical Performance Verification of the Beckman Coulter AU5800 Clinical Chemistry Analyser Against Recognized Quality Specifications Reveals Relevance of Method Harmonization.
    Glibert B; Bourleaux V; Peeters R; Reynolds T; Vranken G
    Clin Lab; 2016; 62(1-2):57-72. PubMed ID: 27012034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers.
    Whitehead SJ; Ford C; Gama R
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):54-67. PubMed ID: 23880620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASVCP guidelines: allowable total error guidelines for biochemistry.
    Harr KE; Flatland B; Nabity M; Freeman KP;
    Vet Clin Pathol; 2013 Dec; 42(4):424-36. PubMed ID: 24320779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical quality of near-patient blood cholesterol and glucose determinations.
    du Plessis M; Ubbink JB; Vermaak WJ
    Clin Chem; 2000 Aug; 46(8 Pt 1):1085-90. PubMed ID: 10926887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of glucose point of care testing in three metropolitan hospitals.
    Sharp L; Farrance I; Greaves RF
    Pathology; 2016 Jan; 48(1):51-9. PubMed ID: 27020210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-analytical errors with portable glucose meters in the hospital setting.
    Carraro P; Plebani M
    Clin Chim Acta; 2009 Jun; 404(1):65-7. PubMed ID: 19298797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of point-of-care testing recertification with e-learning.
    Bikker R; Meyer K; Domberg P; Brand K; Behrends M
    Scand J Clin Lab Invest; 2020; 80(2):133-138. PubMed ID: 31846346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Country reports from Japan: external quality assessment scheme in Japan.
    Tatsumi N; Kawai T; Funahara Y; Sumiyoshi A; Kawano K; Watanabe K; Matsuno K; Takubo T; Tsuda I
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():15-25. PubMed ID: 10926254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoassay external quality assessment in the Federal Republic of Germany.
    Wood WG
    Ann Ist Super Sanita; 1991; 27(3):495-8. PubMed ID: 1809070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.